FAHAM MALEK has a total of 14 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, environmental technology and pharmaceuticals are BEIJING ENTRY EXIT INSPECTION & QUARANTINE BUREAU, PATHOQUEST and CERGENTIS B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Environmental technology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Faham Malek | 14 |
#2 | Willis Thomas | 10 |
#3 | Moorhead Martin | 2 |
#4 | Wang Zhiyong | 1 |
#5 | Moorhead Martin Emilio | 1 |
#6 | Martin Mitchell Lee | 1 |
#7 | Carlton Victoria | 1 |
#8 | Hardenbol Paul | 1 |
#9 | Pepin Francois | 1 |
#10 | Namsaraev Eugeni | 1 |
Publication | Filing date | Title |
---|---|---|
US2013136799A1 | Monitoring health and disease status using clonotype profiles | |
US2013324422A1 | Detecting disease-correlated clonotypes from fixed samples | |
US2011207135A1 | Sequence analysis of complex amplicons | |
US2011207134A1 | Monitoring health and disease status using clonotype profiles | |
WO2005067603A2 | Autism-associated polymorphisms and uses thereof | |
WO2005029040A2 | System and methods for enhancing signal-to-noise ratios of microarray-based measurements |